How Glucosamine and PUGNAc Help Reduce Inflammation in Blood Vessels
Author Information
Author(s): Dongqi Xing, Kaizheng Gong, Wenguang Feng, Susan E. Nozell, Yiu-Fai Chen, John C. Chatham, Suzanne Oparil
Primary Institution: University of Alabama at Birmingham
Hypothesis
Increasing NFκB p65 O-GlcNAc protein modification with GlcN and PUGNAc treatment inhibits TNF-α-induced inflammatory responses in isolated RASMCs by interfering with NFκB signaling.
Conclusion
Glucosamine and PUGNAc treatments inhibit inflammation in vascular smooth muscle cells by modifying NFκB p65, which reduces its activation and the expression of inflammatory mediators.
Supporting Evidence
- Glucosamine and PUGNAc treatments reduced the expression of inflammatory mediators in rat aortic smooth muscle cells.
- Both treatments inhibited TNF-α induced NFκB p65 activation and promoter activity.
- Increased O-GlcNAcylation of NFκB p65 was observed with glucosamine and PUGNAc treatment.
Takeaway
This study shows that two substances, glucosamine and PUGNAc, can help calm down inflammation in blood vessels, which is important for keeping our hearts healthy.
Methodology
Rat aortic smooth muscle cells were treated with glucosamine or PUGNAc and then stimulated with TNF-α to assess inflammatory mediator expression and NFκB signaling.
Limitations
The study's pharmacologic agents may have non-specific effects, and the specific role of O-GlcNAcylation in the observed effects needs further confirmation.
Participant Demographics
Quiescent rat aortic smooth muscle cells from female Sprague-Dawley rats.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website